Development and Validation of a HPLC‐MS/MS Method for the Determination of Compound 13b in Rat Plasma and Its Application to a Pharmacokinetic Study
Guofang Bi(National Medical Products Administration), Huichang Bi(Southern Medical University), Jiayin Guo(Guangdong Pharmaceutical University), Yang Xiao(Memorial Sloan Kettering Cancer Center), Xiaowen Jiang(Southern Medical University), Jian‐Hong Fang(University of Electronic Science and Technology of China), Peng Wang(Advanced Institute of Materials Science), Shuang Hu(South China University of Technology), Shuqing Zhang(Qingdao Agricultural University), Chenghua Wu(Guangdong Pharmaceutical University), Qingqing Yu(Guangdong Pharmaceutical University), Yuhua Long(South China Normal University)
Cited by 2
Related Papers
Current trends in drug metabolism and pharmacokinetics
|Acta Pharmaceutica Sinica B|2019|391
SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation
|Acta Pharmaceutica Sinica B|2020|129
Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells
|Analytical and Bioanalytical Chemistry|2013|126
Hepato-protective effect of resveratrol against acetaminophen-induced liver injury is associated with inhibition of CYP-mediated bioactivation and regulation of SIRT1–p53 signaling pathways
|Toxicology Letters|2015|122
Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation
|Chemico-Biological Interactions|2015|117